134 related articles for article (PubMed ID: 1412762)
1. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
Wang ME; Stepkowski SM; Ferraresso M; Kahan BD
Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
3. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
Chen H; Wu J; Xu D; Luo H; Daloze PM
Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.
Stepkowski SM; Chen H; Daloze P; Kahan BD
Transplantation; 1991 Jan; 51(1):22-6. PubMed ID: 1987691
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
[TBL] [Abstract][Full Text] [Related]
7. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival.
Boyle MJ; Baghdassarian V; Stepkowski SM; Dumble LJ; Kahan BD
Cell Transplant; 1998; 7(3):247-56. PubMed ID: 9647434
[TBL] [Abstract][Full Text] [Related]
8. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
Boyle MJ; Dumble LJ
Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
[TBL] [Abstract][Full Text] [Related]
9. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
Ferraresso M; Wang ME; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
[No Abstract] [Full Text] [Related]
10. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival.
Hamashima T; Stepkowski SM; Chou TC; Kahan BD
Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153
[TBL] [Abstract][Full Text] [Related]
11. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
Yoshimura N; Kahan BD
Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
[TBL] [Abstract][Full Text] [Related]
12. Soluble antigen and cyclosporine-induced specific unresponsiveness in rats. Frequency of alloantigen-specific T cytotoxic cells in normal, sensitized, and unresponsive rats.
Ito T; Stepkowski SM; Kahan BD
Transplantation; 1990 Feb; 49(2):422-8. PubMed ID: 2137656
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
[No Abstract] [Full Text] [Related]
15. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of in vitro immune responses of T and B cells during tolerance induction by sirolimus.
Ghobrial R; Karczewski M; Ferraresso M; Tian L; Stepkowski SM; Kahan BD
Ann Transplant; 1996; 1(4):22-9. PubMed ID: 9869901
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Stepkowski SM; Kahan BD
Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
[No Abstract] [Full Text] [Related]
18. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
[No Abstract] [Full Text] [Related]
19. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
[No Abstract] [Full Text] [Related]
20. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
